Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q1 2022
Institutional positions in Verona Pharma plc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −3 vs. Q4 2021
- Shares held
- 36.4M
- −492.3K (−1.3%) vs. Q4 2021
- Total value
- $181.7M
- −$66.3M (−26.7%) vs. Q4 2021
- New holders
- 4
- 9 more added
- Sold out
- 7
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 79 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 595 | $3.00K | 0.00% | −397−40.0% | Reduced |
| UBS Group AG | 655 | $3.00K | 0.00% | +655 | New |
| Federation des caisses Desjardins du Quebec | 650 | $3.24K | 0.00% | +650 | New |
| Plante Moran Financial Advisors, LLC | 892 | $4.00K | 0.00% | 00.0% | Unchanged |
| Brewin Dolphin Ltd | 726 | $4.00K | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 1,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,031 | $5.00K | 0.00% | +698+209.6% | Added |
| Endurance Wealth Management, Inc. | 2,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 3,840 | $19.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 5,752 | $28.0K | 0.00% | +1,380+31.6% | Added |
| Morgan Stanley | 9,453 | $47.0K | 0.00% | +2,185+30.1% | Added |
| IPG Investment Advisors LLC | 11,900 | $59.0K | 0.01% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 13,150 | $66.0K | 0.01% | +13,150 | New |
| Geode Capital Management, LLC | 14,437 | $72.0K | 0.00% | +1,164+8.8% | Added |
| HSBC Holdings PLC | 15,041 | $79.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 18,333 | $91.0K | 0.00% | −12,447−40.4% | Reduced |
| Millennium Management LLC | 26,799 | $134.0K | 0.00% | +10,830+67.8% | Added |
| Forefront Analytics, LLC | 35,656 | $179.0K | 0.07% | +1,550+4.5% | Added |
| D.A. Davidson & Co. | 48,000 | $240.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 58,400 | $292.0K | 0.00% | +400+0.7% | Added |
| venBio Partners LLC | 161,897 | $808.0K | 0.18% | 00.0% | Unchanged |
| Logos Global Management LP | 300,000 | $1.50M | 0.19% | +178,000+145.9% | Added |
| Citigroup Inc | 369,008 | $1.84M | 0.00% | +369,008 | New |
| Sphera Funds Management Ltd. | 666,339 | $3.33M | 0.56% | −134,917−16.8% | Reduced |
| Ghost Tree Capital, LLC | 750,000 | $3.74M | 1.85% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 751,905 | $3.75M | 0.13% | 00.0% | Unchanged |
| Novo Holdings A/S | 761,205 | $3.80M | 0.20% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 926,602 | $4.62M | 1.09% | 00.0% | Unchanged |
| Foresite Capital Management III, LLC | 1,111,112 | $5.54M | 16.89% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,111,112 | $5.54M | 1.40% | 00.0% | Unchanged |
| Aisling Capital Management LP | 1,332,485 | $6.65M | 3.59% | 00.0% | Unchanged |
| Abingworth LLP | 2,457,499 | $12.1M | 3.44% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,749,918 | $13.7M | 0.94% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,044,303 | $15.2M | 0.32% | +176,793+6.2% | Added |
| Wellington Management Group LLP | 3,778,785 | $18.9M | 0.00% | −1,053,203−21.8% | Reduced |
| Ra Capital Management, L.P. | 5,100,000 | $25.4M | 0.56% | 00.0% | Unchanged |
| NEA Management Company, LLC | 5,108,563 | $25.5M | 0.82% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 5,694,841 | $28.4M | 0.46% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −12,263−100.0% | Sold out |
| Rathbone Brothers plc | 0 | $0 | 0.00% | −11,959−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,889−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −826−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −238−100.0% | Sold out |